[Topical treatment of erectile dysfunction. Possibilities and perspectives].

In this work the Authors speak about topical treatment in diagnosis and therapy of erectile deficit with prostaglandin, papaverine, phentolamine, V.I.P.

[The "aging" of the male genital system: erection].

Between 1/2/89 and 31/1/92 we have studied 300 old patients (the average patient age was 72 years). We used scores of sexual functionality to study the accordances between voluntary and spontaneous erection, the characteristics of the erection per age, the frequency of intercourse per age, the sexual preferences in males and females. Also the partner's extrangement has been valued.

[Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].

The authors present the long-term of adjuvant chemotherapy using M-VEC scheme (Mtx 20 mg/mq; vinblastine 0.1 mg/kg; CDDP 40 mg/mq; epirubicin 30 mg/mq each 21 day for six cycles) effected in 28 patients (21 males and 7 women with average age of 67) undergone radical cystectomy for invasive bladder carcinoma p G2-3 T-4 N + M0. Total survival after 5 years was 28.

[Complications of intracavernous pharmacologic infusion in impotence. Long-term results].

The large scale employment in recent years of vasoactive drugs in the treatment of impotence forms the basis for a significant statistical study on incidence of complications and collateral effects. We studied 658 patients submitted to ICF (intracavernous pharmacoinfusion) diagnostic and therapeutic in the last 6 years (1986-1992). The patients have been shared groups according to the period and the treatment: in 226 cases we have utilized papaverine, in 224 cases phentolamine-papaverine association and in 208 cases prostaglandin E1.

[Adjuvant chemo-immunotherapy with VBL + INF in renal carcinoma. Long-term results].

Authors show results of adjuvant chemoimmunotherapeutic approach (0, 10 mg/kg Vinblastine every three weeks plus INF - alpha 2a - and INF - alpha 2b in a dose of 3 x 10(6) U.I. three times a week) adopted after radical nephrectomy in 45 patients with renal carcinoma (p.